Cargando…
Scripted spot removal in PBS proton therapy planning
BACKGROUND: It is well known in proton therapy that the relative biological effectiveness (RBE) is not constant across the entire Bragg peak, with higher RBE at the distal end of the Bragg peak due to higher linear energy transfer (LET). Treatment planning systems are moving toward LET optimization...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833280/ https://www.ncbi.nlm.nih.gov/pubmed/34890101 http://dx.doi.org/10.1002/acm2.13491 |
_version_ | 1784648897015054336 |
---|---|
author | Hedrick, Samantha G. Walker, Bryant Morris, Bart Petro, Scott Blakey, Marc |
author_facet | Hedrick, Samantha G. Walker, Bryant Morris, Bart Petro, Scott Blakey, Marc |
author_sort | Hedrick, Samantha G. |
collection | PubMed |
description | BACKGROUND: It is well known in proton therapy that the relative biological effectiveness (RBE) is not constant across the entire Bragg peak, with higher RBE at the distal end of the Bragg peak due to higher linear energy transfer (LET). Treatment planning systems are moving toward LET optimization to mitigate this potentially higher biological impact at a track end. However, using a simple script, proton users can begin to simulate this process by deleting spots from critical structures during optimization. In most cases, nominal target coverage and plan robustness remain satisfactory. METHODS: In our clinic, we developed a script that allows the user to delete spots in all organs at risk (OARs) of interest for one or more treatment beams. The purpose of this script is to potentially reduce side effects by eliminating Bragg peaks within OARs. The script was first used for prostate patients where spots in the rectum and sigmoid, outside of the overlap with the target, were deleted. We then began to use the script for head and neck (H&N) and breast/chestwall patients to reduce acute side effects of the skin by removing spots in a 0.5‐cm skin rind. CONCLUSIONS: By utilizing a simple script for deleting spots in critical structures, we have seen excellent clinical results thus far. We have noted reduced skin reactions for nearly all H&N and breast patients. |
format | Online Article Text |
id | pubmed-8833280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88332802022-02-14 Scripted spot removal in PBS proton therapy planning Hedrick, Samantha G. Walker, Bryant Morris, Bart Petro, Scott Blakey, Marc J Appl Clin Med Phys Technical Notes BACKGROUND: It is well known in proton therapy that the relative biological effectiveness (RBE) is not constant across the entire Bragg peak, with higher RBE at the distal end of the Bragg peak due to higher linear energy transfer (LET). Treatment planning systems are moving toward LET optimization to mitigate this potentially higher biological impact at a track end. However, using a simple script, proton users can begin to simulate this process by deleting spots from critical structures during optimization. In most cases, nominal target coverage and plan robustness remain satisfactory. METHODS: In our clinic, we developed a script that allows the user to delete spots in all organs at risk (OARs) of interest for one or more treatment beams. The purpose of this script is to potentially reduce side effects by eliminating Bragg peaks within OARs. The script was first used for prostate patients where spots in the rectum and sigmoid, outside of the overlap with the target, were deleted. We then began to use the script for head and neck (H&N) and breast/chestwall patients to reduce acute side effects of the skin by removing spots in a 0.5‐cm skin rind. CONCLUSIONS: By utilizing a simple script for deleting spots in critical structures, we have seen excellent clinical results thus far. We have noted reduced skin reactions for nearly all H&N and breast patients. John Wiley and Sons Inc. 2021-12-10 /pmc/articles/PMC8833280/ /pubmed/34890101 http://dx.doi.org/10.1002/acm2.13491 Text en © 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Technical Notes Hedrick, Samantha G. Walker, Bryant Morris, Bart Petro, Scott Blakey, Marc Scripted spot removal in PBS proton therapy planning |
title | Scripted spot removal in PBS proton therapy planning |
title_full | Scripted spot removal in PBS proton therapy planning |
title_fullStr | Scripted spot removal in PBS proton therapy planning |
title_full_unstemmed | Scripted spot removal in PBS proton therapy planning |
title_short | Scripted spot removal in PBS proton therapy planning |
title_sort | scripted spot removal in pbs proton therapy planning |
topic | Technical Notes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833280/ https://www.ncbi.nlm.nih.gov/pubmed/34890101 http://dx.doi.org/10.1002/acm2.13491 |
work_keys_str_mv | AT hedricksamanthag scriptedspotremovalinpbsprotontherapyplanning AT walkerbryant scriptedspotremovalinpbsprotontherapyplanning AT morrisbart scriptedspotremovalinpbsprotontherapyplanning AT petroscott scriptedspotremovalinpbsprotontherapyplanning AT blakeymarc scriptedspotremovalinpbsprotontherapyplanning |